• Home
• About Us
  • Leadership
  • Directors
  • Scientific Advisors
• About rEEG
• Research
• Physician
• Patients
  • Find a Physician
  • rEEG Process
  • FAQ
• Payers
• Investors
• Contact Us

What is Referenced-EEG^® (rEEG^®)

Recent Updates^®

Referenced-EEG (rEEG) is a novel assessment tool which helps physicians understand the neurophysiology of their patients.

Personalized Medicine meets Psychiatry

One in four Americans will suffer a diagnosable mental illness in any given year. And when that happens, their physicians will have over 130 psychotropic drugs from which to choose, but only subjective, patient-reported symptoms on which to base their treatment. Unfortunately, the dominant approach to prescribing in psychiatry is “trial and error” medicine, so it’s no surprise that treatment failures in disorders like depression range from 40 to 60 percent.

Physicians have long sought some sort of objective, patient-based physiology data -- like the x-rays, EKG or blood tests used in general medicine -- to assist them in clinical decision making.

The Benefits of rEEG^®

Patient Benefit

Physicians using Referenced-EEG® (rEEG®) in clinical trials have achieved superior clinical response and remission compared to physicians using Trial and Error.

Physician Benefit

Physicians have long sought some sort of objective information about the brains that they're treating. rEEG® offers objective, statistical data on patient neurophysiology which physicians find useful, especially for their patients who have failed two or more medications.

Payer Benefit

Payers have long known that plan members with treatment-resistant behavioral disorders have direct medical expenditures (non-behavioral) that average four times higher than non treatment-resistant members and pharmaceutical costs that are almost seven times higher. Published studies of commercial claim data have assessed the total cost at $8,500 annually per treatment resistant member.

What does a report look like?